United States · FDA National Drug Code directory

VIR Combination

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43742-2539_2413e6df-b75a-43da-859c-7d596587764e
Product NDC
43742-2539
Form
LIQUID
Composition / generic term
Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 and 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex I and II Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum
Labeler
Deseret Biologicals, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20260326
Source listing expiry
20271231

Source-listed ingredients

  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN — 12 [hp_C]/mL
  • HUMAN HERPESVIRUS 5 — 18 [hp_X]/mL
  • HERRING SPERM DNA — 12 [hp_X]/mL
  • HUMAN HERPESVIRUS 4 — 16 [hp_C]/mL
  • HEPATITIS B VIRUS — 33 [hp_X]/mL
  • HUMAN HERPESVIRUS 1 — 15 [hp_X]/mL
  • HUMAN HERPESVIRUS 2 — 15 [hp_X]/mL
  • HUMAN HERPESVIRUS 6 — 15 [hp_X]/mL
  • INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_C]/mL
  • INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_C]/mL
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE — 12 [hp_C]/mL
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE — 12 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (43742-2539-1) · 43742-2539-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →